NCT01957228|Completed
Loading search results
Sponsor study identifier
Secondary identifiers
OTHER · AP HM
interventional
980
1 country
1
Study Start
October 7, 2013
Actual (reported)Primary Completion
September 30, 2019
Actual (reported)Study Completion
October 26, 2022
Actual (reported)On joint orthopaedic hardware infections are one of the most frequently encountered complications in orthopaedic surgery. However 6% of the cultures remain sterile, etiological diagnosis cannot be established despite obvious signs of infection. As part of this research project, we have developed a new strategy diagnosis including directly the use of PCR to reduce the number of negative results. This should have a major therapeutic impact in terms of timeliness and specificity of antibiotic. Primary: Evaluate the effectiveness of the new diagnostic strategy on etiological identification of prosthesis infections. Hypothesis: Minimum 6 percent increase in the number of patients with an etiological diagnosis of infection on prosthesis.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 26, 2022
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 30, 2013
Actual (reported)October 7, 2013
Actual (reported)October 8, 2013
Actual (reported)September 30, 2019
Actual (reported)October 26, 2022
Actual (reported)Bone biopsies multisite
Increase of at least 6% of patients with an etiologic diagnosis of prosthesis infection established.
4 years
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Assistance Publique Hopitaux de Marseille
Marseille, 13354, France
LOIC MONDOLONI
Assistance Publique Hopitaux De Marseille
980 participants (actual enrollment reported by the registry).
First Submitted
September 30, 2013
First Posted
October 8, 2013
Study Start
October 7, 2013
Actual (reported)Clindamycin for the treatment of infections: the influence of rifampicin and obesity on PK/PD target attainment
Contact the study team to confirm eligibility.
Primary Completion
September 30, 2019
Actual (reported)Study Completion
October 26, 2022
Actual (reported)Last Updated
April 21, 2023
Record last verified: 2023-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: